Yes. As of September 2026, iShares MSCI World Islamic UCITS ETF (ISWD.L) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. iShares MSCI World Islamic UCITS ETF passes Musaffa's business and financial screening criteria.
ISWD.L was created on 2007-12-07 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 944.72m in AUM and 395 holdings. The Fund seeks to track the performance of an index composed of companies from developed countries and which comply with Shariah investment principles.
iShares MSCI World Islamic UCITS ETF (ISWD.L) Chart
Key Statistics of iShares MSCI World Islamic UCITS ETF (ISWD.L)
Today's Open
-
AUM
-
Avg. Volume
-
Expense Ratio
-
P/E Ratio
-
P/B Ratio
-
FAQ's for iShares MSCI World Islamic UCITS ETF (ISWD.L)
As of September 2026, iShares MSCI World Islamic UCITS ETF ISWD.L is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes iShares MSCI World Islamic UCITS ETF using these criteria to determine its compliance status.
The Shariah compliance status of iShares MSCI World Islamic UCITS ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of iShares MSCI World Islamic UCITS ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.